A Phase II Study to Evaluate Recombinant Platelet-Derived Growth Factor-BB in the Treatment of Stage 3 and 4 Pressure Ulcers

1994175 citationsJournal Article

Authors

Thomas A. Mustoe · Northwestern Medical Faculty Foundation

Abstract

Data from this small trial suggest that local application of rPDGF-BB may be of therapeutic benefit in accelerating the healing of chronic pressure ulcers.

Topics & Keywords

Pressure Ulcer Prevention and Management Wound Healing and Treatments Surgical site infection prevention

Publication Details

Published in: Archives of Surgery

Volume 129, Issue 2, pp. 213-213

DOI: 10.1001/archsurg.1994.01420260109015

Field-Weighted Citation Impact: 25.77

Command Palette

A Phase II Study to Evaluate Recombinant Platelet-Derived Growth Factor-BB in the Treatment of Stage 3 and 4 Pressure Ulcers

Authors

Abstract

Topics & Keywords

Publication Details